Document is current
Any future updates will be listed below
-
Authors
Shah, Ayesha
Pakneeshan, Sahar
Jones, Michael P
Koloski, Natasha
Callaghan, Gavin
Morrison, Mark
Holtmann, Gerald https://orcid.org/0000-0002-0206-2358
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (APP1200184)
- License Information
-
More Information
Article History
Received: 11 June 2022
Accepted: 19 July 2022
First Online: 10 October 2022
Declarations
:
: None
: Prof Gerald Holtmann
: GH reports to be on the advisory boards Australian Biotherapeutics, Glutagen, and Bayer, and received research support from Bayer, Abbott, Pfizer, Janssen, Takeda, and Allergan. He serves on the Boards of the West Moreton Hospital and Health Service, Queensland, UQ Healthcare, Brisbane, and the Gastro-Liga, Germany. He has a patent for the Brisbane aseptic biopsy device and serves as Editor of the Gastro-Liga Newsletter. MM serves on the scientific advisory board (honorary) for Genie Biome (Hong Kong) and received research support from Bayer and Soho Flordis International (SFI) Health. AS, SP, MPJ, NK, and GCÂ declare no competing interests.
: The author is solely responsible for the data and the contents of the paper. In no way is the honorary editor in chief, editorial board members, the Indian Society of Gastroenterology, or the printer/publishers responsible for the results/findings and content of this article Indian Journal of Gastroenterology.
